Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine treatment in RLS patients with insufficient response to shorter-acting dopamine agonists
2011-004825-29Phase 4Active
- Sponsor
- Instituto de Investigaciones del Sueño
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rotigotine in restless legs syndrome (RLS), sponsored by Instituto de Investigaciones del Sueño. Primary endpoint: Change in m-SIT disturbance index (SIT-DI). Started Nov 2011; status: active.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2011-004825-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004825-29.